The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease

被引:94
|
作者
Song, Myeong Jun [1 ,2 ]
Malhi, Harmeet [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea
关键词
Nonalcoholic steatohepatitis; Lipotoxicity; Endoplasmic reticulum stress; Palmitate; Sphingolipids; ENDOPLASMIC-RETICULUM-STRESS; QUALITY-CONTROL PROTEINS; GROWTH-FACTOR; 21; ER-STRESS; TRANSCRIPTION FACTOR; URSODEOXYCHOLIC ACID; NONALCOHOLIC STEATOHEPATITIS; TAUROURSODEOXYCHOLIC ACID; MESSENGER-RNAS; TRANSMEMBRANE PROTEIN;
D O I
10.1016/j.pharmthera.2019.107401
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nonalcoholic fatty liver disease is a major public health burden. Although many features of nonalcoholic fatty liver disease pathogenesis are known, the specific mechanisms and susceptibilities that determine an individual's risk of developing nonalcoholic steatohepatitis versus isolated steatosis are not well delineated. The predominant and defining histologic and imaging characteristic of nonalcoholic fatty liver disease is the accumulation of lipids. Dysregulation of lipid homeostasis in hepatocytes leads to transient generation or accumulation of toxic lipids that result in endoplasmic reticulum (ER) stress with inflammation, hepatocellular damage, and apoptosis. ER stress activates the unfolded protein response(UPR)which is classically viewed as an adaptive pathway to maintain protein folding homeostasis. Recent studies have uncovered the contribution of the UPR sensors in the regulation of hepatic steatosis and in the cellular response to lipotoxic stress. Interestingly, theUPR sensors can be directly activated by toxic lipids, independently of the accumulation of misfolded proteins, termed lipotoxic and proteotoxic stress, respectively. The dual function of the UPR sensors in protein and lipid homeostasis suggests that these two types of stress are interconnected likely due to the central role of the ER in protein folding and trafficking and lipid biosynthesis and trafficking, such that perturbations in either impact the function of the ER and activate the UPR sensors in an effort to restore homeostasis. The precise molecular similarities and differences between proteotoxic and lipotoxic ER stress are beginning to be understood. Herein, we provide an overview of the mechanisms involved in the activation and cross-talk between the UPR sensors, hepatic lipid metabolism, and lipotoxic stress, and discuss the possible therapeutic potential of targeting the UPR in nonalcoholic fatty liver disease. (C) 2019 Published by Elsevier Inc.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Hepatic RIPK3 signalling differentially modulates lipid metabolism and inflammation in non-alcoholic fatty liver disease
    Afonso, Marta B.
    Miguel Rodrigues, Pedro
    Mateus-Pinheiro, Miguel
    Simao, Andre L.
    Gaspar, Maria Manuela
    Majdi, Amine
    Ratziu, Vlad
    Banales, Jesus M.
    Gautheron, Jeremie
    Castro, Rui E.
    Rodrigues, Cecilia M. P.
    JOURNAL OF HEPATOLOGY, 2020, 73 : S672 - S672
  • [32] LncRNA H19 IN HEPATIC LIPID METABOLISM AND ALCOHOLIC FATTY LIVER
    Wang, L.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2017, 41 : 324A - 324A
  • [33] Oxidative Stress and the Unfolded Protein Response: A Disconnect in Alcoholic Liver Disease
    Galligan, James
    Fritz, Kris
    Smathers, Rebecca
    Shearn, Colin
    Petersen, Dennis
    FREE RADICAL BIOLOGY AND MEDICINE, 2010, 49 : S94 - S95
  • [34] Itaconic acid underpins hepatocyte lipid metabolism in non-alcoholic fatty liver disease
    Weiss, Jonathan M.
    Palmieri, Erika M.
    Gonzalez-Cotto, Marieli M.
    Bettencourt, Ian A.
    Megill, Emily L.
    Snyder, Nathaniel W.
    McVicar, Daniel W.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [35] Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease
    Su, Xin
    Kong, Yi
    Peng, Daoquan
    CLINICA CHIMICA ACTA, 2019, 498 : 30 - 37
  • [36] Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease
    Ting Li
    Hua Yan
    Yan Geng
    Haitao Shi
    Hong Li
    Shenhao Wang
    Yatao Wang
    Jingyuan Xu
    Gang Zhao
    Xiaolan Lu
    Lipids in Health and Disease, 18
  • [37] Non-Alcoholic Fatty Liver Disease Risk SNP Variants Affect Lipid Metabolism
    Ikezaki, Hiroaki
    Murata, Masayuki
    Shimono, Nobuyuki
    Schaefer, Ernst J.
    CIRCULATION, 2023, 148
  • [38] Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease
    Li, Ting
    Yan, Hua
    Geng, Yan
    Shi, Haitao
    Li, Hong
    Wang, Shenhao
    Wang, Yatao
    Xu, Jingyuan
    Zhao, Gang
    Lu, Xiaolan
    LIPIDS IN HEALTH AND DISEASE, 2019, 18 (01)
  • [39] Effects of Thyroid Hormones on Lipid Metabolism Pathologies in Non-Alcoholic Fatty Liver Disease
    Liao, Chia-Jung
    Huang, Po-Shuan
    Chien, Hui-Tzu
    Lin, Tzu-Kang
    Yeh, Chau-Ting
    Lin, Kwang-Huei
    BIOMEDICINES, 2022, 10 (06)
  • [40] Impaired hepatic lipid metabolism and biomarkers in fatty liver disease
    Teixeira, Francisca S.
    Pimentel, Ligia L.
    Pintado, Manuela E.
    Rodriguez-Alcala, Luis M.
    BIOCHIMIE, 2023, 215 : 69 - 74